Dr. Stephen Howard Mandy, MD

Dr. Mandy practices at UMiami Medicine - Dermatology in Miami, Florida.

Dr. Mandy's NPI, 1528063112, was assigned on June 20, 2005. Dr. Mandy graduated from George Washington University School of Medicine and Health Sciences in 1966. Dr. Mandy holds Florida license ME12999.

Dr. Mandy's primary practice is UMiami Medicine - Dermatology, at 1444 NW 9th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Dr. Mandy's primary practice is UMiami Medicine - Dermatology in Miami, Florida. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Mandy to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mandy practices. Vendor and product names are available with a free account.

Dermatology is Dr. Mandy's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Mandy is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Mandy's licenses on file in 3 states: Florida, Colorado and Maryland.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, rash, scalp rash, skin cyst and skin discoloration among the conditions Dr. Mandy treats.

CMS data shows 452 Medicare services from Dr. Mandy across 7 procedure codes in 2024, for 111 Medicare patients. Medicare paid $14,678 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Dr. Mandy in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mandy's median patient age at 53, with 40% women.

In 2024, Dr. Mandy wrote 80 Medicare Part D claims for 42 patients. 99% of them were for generic drugs. CMS names the drug for 22 of them, across 1 drug with 11 or more claims each, at $124 in total drug cost. In 2023, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Mandy for performance year 2024, reported as part of a group. Dr. Mandy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of removal of skin lesions by Dr. Mandy, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Mandy, published from 2019 to 2023. The most frequent topics are Skin Aging, Cosmetic Techniques and Rejuvenation. Dr. Mandy has published most often in Dermatol Surg. Dr. Mandy's most frequent co-authors are Roberta Spencer Del Campo, MD, Glynis Reina Ablon, MD and Shasa Hu, MD.

CMS Open Payments shows 66 general payments to Dr. Mandy from 16 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 51% of the total. Almirall LLC paid the most, $9,954.

Dmand AI lists 2 awards for Dr. Mandy.

Dr. Mandy graduated from George Washington University School of Medicine and Health Sciences in 1966. Dr. Mandy is a member of AAD.

Dr. Mandy is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.